AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 132 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $2,728 | -96.1% | 880 | -97.5% | 0.00% | – |
Q4 2022 | $70,709 | -91.7% | 35,532 | -91.6% | 0.00% | -100.0% |
Q3 2022 | $850,000 | -45.7% | 421,009 | -14.5% | 0.00% | 0.0% |
Q2 2022 | $1,565,000 | +212.4% | 492,288 | +309.7% | 0.00% | – |
Q1 2022 | $501,000 | -8.1% | 120,160 | +5.5% | 0.00% | – |
Q4 2021 | $545,000 | +185.3% | 113,854 | +218.5% | 0.00% | – |
Q3 2021 | $191,000 | +55.3% | 35,752 | +48.7% | 0.00% | – |
Q2 2021 | $123,000 | -27.2% | 24,039 | -4.4% | 0.00% | – |
Q1 2021 | $169,000 | +1026.7% | 25,134 | +555.2% | 0.00% | – |
Q3 2020 | $15,000 | -89.5% | 3,836 | -90.7% | 0.00% | -100.0% |
Q1 2020 | $143,000 | -50.5% | 41,133 | -31.4% | 0.00% | -50.0% |
Q4 2019 | $289,000 | +158.0% | 59,988 | +54.8% | 0.00% | +100.0% |
Q3 2019 | $112,000 | +1020.0% | 38,751 | +2570.6% | 0.00% | – |
Q2 2019 | $10,000 | -98.7% | 1,451 | -95.7% | 0.00% | -100.0% |
Q3 2018 | $756,000 | -10.8% | 34,090 | -34.0% | 0.01% | -14.3% |
Q2 2018 | $848,000 | – | 51,690 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fosun International Ltd | 21,521,301 | $144,839,000 | 11.40% |
Eversept Partners, LP | 4,755,480 | $32,004,380 | 2.41% |
TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $109,116,000 | 1.27% |
EAM Global Investors LLC | 365,719 | $2,461,000 | 0.68% |
Signature Wealth Management Partners, LLC | 87,666 | $590,000 | 0.57% |
Jackson Creek Investment Advisors LLC | 221,043 | $1,488,000 | 0.52% |
Tranquilli Financial Advisor LLC | 71,414 | $481,000 | 0.39% |
Hillsdale Investment Management Inc. | 611,200 | $4,113,000 | 0.34% |
EAM Investors, LLC | 259,873 | $1,749,000 | 0.26% |
HUSSMAN STRATEGIC ADVISORS, INC. | 180,000 | $1,211,000 | 0.25% |